Epidermal growth factor receptor immunohistochemistry: New opportunities in metastatic colorectal cancer

Simple item page
dc.contributor.authorHutchinson, Ryan A.
dc.contributor.authorAdams, Richard A.
dc.contributor.authorMcArt, Darragh G.
dc.contributor.authorSalto-Tellez, Manuel
dc.contributor.authorJasani, Bharat
dc.contributor.authorHamilton, Peter W.
dc.date.accessioned2017-01-12T09:18:13Z
dc.date.available2017-01-12T09:18:13Z
dc.date.issued2015-07-07
dc.description.abstractThe treatment of cancer is becoming more precise, targeting specific oncogenic drivers with targeted molecular therapies. The epidermal growth factor receptor has been found to be over-expressed in a multitude of solid tumours. Immunohistochemistry is widely used in the fields of diagnostic and personalised medicine to localise and visualise disease specific proteins. To date the clinical utility of epidermal growth factor receptor immunohistochemistry in determining monoclonal antibody efficacy has remained somewhat inconclusive. The lack of an agreed reproducible scoring criteria for epidermal growth factor receptor immunohistochemistry has, in various clinical trials yielded conflicting results as to the use of epidermal growth factor receptor immunohistochemistry assay as a companion diagnostic. This has resulted in this test being removed from the licence for the drug panitumumab and not performed in clinical practice for cetuximab. In this review we explore the reasons behind this with a particular emphasis on colorectal cancer, and to suggest a way of resolving the situation through improving the precision of epidermal growth factor receptor immunohistochemistry with quantitative image analysis of digitised images complemented with companion molecular morphological techniques such as in situ hybridisation and section based gene mutation analysis.ru_RU
dc.identifier.citationHutchinson, R. A., Adams, R. A., McArt, D. G., Salto-Tellez, M., Jasani, B., & Hamilton, P. W. (2015). Epidermal growth factor receptor immunohistochemistry: New opportunities in metastatic colorectal cancer. Journal of Translational Medicine, 13(1), [217]. DOI: 10.1186/s12967-015-0531-zru_RU
dc.identifier.urihttp://nur.nu.edu.kz/handle/123456789/2253
dc.language.isoenru_RU
dc.publisherJournal of Translational Medicineru_RU
dc.rightsAttribution-NonCommercial-ShareAlike 3.0 United States*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-sa/3.0/us/*
dc.subjectepidermal growth factor receptorru_RU
dc.subjectheterogeneityru_RU
dc.subjectimage analysisru_RU
dc.subjectimmunohistochemistryru_RU
dc.subjectlocalisationru_RU
dc.subjectmetastatic colorectal cancerru_RU
dc.subjectpersonalised medicineru_RU
dc.titleEpidermal growth factor receptor immunohistochemistry: New opportunities in metastatic colorectal cancerru_RU
dc.typeArticleru_RU

Files

Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
Ryan A. Hutchinson, Richard A. Adams.pdf
Size:
16.75 KB
Format:
Adobe Portable Document Format
Description:
Download
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
6.22 KB
Format:
Item-specific license agreed upon to submission
Description:
Download

Collections

Articles